Decreased Clearance of CNS β-Amyloid in Alzheimer's Disease

被引：1597
|
作者：
Mawuenyega, Kwasi G. [1 ]
Sigurdson, Wendy [1 ,2 ]
Ovod, Vitaliy [1 ]
Munsell, Ling [1 ]
Kasten, Tom [1 ]
Morris, John C. [1 ,2 ,3 ]
Yarasheski, Kevin E. [4 ]
Bateman, Randall J. [1 ,2 ,5 ]
机构：
[1] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA
[2] Washington Univ, Sch Med, Alzheimers Dis Res Ctr, St Louis, MO 63110 USA
[3] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA
[4] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA
[5] Washington Univ, Sch Med, Hope Ctr Neurol Disorders, St Louis, MO 63110 USA
来源：
SCIENCE | 2010年 / 330卷 / 6012期
关键词：
IN-VIVO;
D O I：
10.1126/science.1197623
中图分类号：
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号：
07 ; 0710 ; 09 ;
摘要：
[No abstract available]
引用
收藏
页码：1774 / 1774
页数：1
相关论文
共 50 条
  • [31] Erratum to: Animal Models of Alzheimer’s Disease: Utilization of Transgenic Alzheimer’s Disease Models in Studies of Amyloid Beta Clearance
    Tarja Malm
    Johanna Magga
    Jari Koistinaho
    Current Translational Geriatrics and Experimental Gerontology Reports, 2012, 1 (2): : 53 - 58
  • [32] Promising advances in Alzheimer's treatment: donanemab's impact on disease progression and amyloid clearance
    Wahid, Abdul
    Fatima Khan, Wajiha
    Khan, Yusra
    THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2024, 17
  • [33] Amyloid and Alzheimer's disease
    Lei, Hongxing
    PROTEIN & CELL, 2010, 1 (04) : 312 - 314
  • [34] The Amyloid Hypothesis and the clearance and degradation of Alzheimer's β-peptide
    LeVine, H
    JOURNAL OF ALZHEIMERS DISEASE, 2004, 6 (03) : 303 - 314
  • [35] Microfluidic dissociation and clearance of Alzheimer's β-amyloid aggregates
    Lee, Joon Seok
    Park, Chan Beum
    BIOMATERIALS, 2010, 31 (26) : 6789 - 6795
  • [36] Potential biomarker for amyloid clearance in Alzheimer's disease may enable personalized therapy
    不详
    PERSONALIZED MEDICINE, 2011, 8 (03) : 299 - 299
  • [37] Mechanisms of Amyloid-β Peptide Clearance: Potential Therapeutic Targets for Alzheimer's Disease
    Yoon, Sang-Sun
    Jo, Sangmee Ahn
    BIOMOLECULES & THERAPEUTICS, 2012, 20 (03) : 245 - 255
  • [38] Microglial mechanisms drive amyloid-β clearance in immunized patients with Alzheimer's disease
    van Olst, Lynn
    Simonton, Brooke
    Edwards, Alex J.
    Forsyth, Anne V.
    Boles, Jake
    Jamshidi, Pouya
    Watson, Thomas
    Shepard, Nate
    Krainc, Talia
    Argue, Benney M. R.
    Zhang, Ziyang
    Kuruvilla, Joshua
    Camp, Lily
    Li, Mengwei
    Xu, Hang
    Norman, Jeanette L.
    Cahan, Joshua
    Vassar, Robert
    Chen, Jinmiao
    Castellani, Rudolph J.
    Nicoll, James A. R.
    Boche, Delphine
    Gate, David
    NATURE MEDICINE, 2025,
  • [39] Unlocking the therapeutic promise of miRNAs in promoting amyloid-β clearance for Alzheimer's disease
    Kaur, Vajinder
    Sunkaria, Aditya
    BEHAVIOURAL BRAIN RESEARCH, 2025, 484
  • [40] Genetic Analysis of Genes Involved in Amyloid-β Degradation and Clearance in Alzheimer's Disease
    Natunen, Teemu
    Helisalmi, Seppo
    Vepsalainen, Saila
    Sarajarvi, Timo
    Antikainen, Leila
    Makinen, Petra
    Herukka, Sanna-Kaisa
    Koivisto, Anne Maria
    Haapasalo, Annakaisa
    Soininen, Hilkka
    Hiltunen, Mikko
    JOURNAL OF ALZHEIMERS DISEASE, 2012, 28 (03) : 553 - 559
12345